Celastrol synergizes with MEK1 inhibitor nedometinib to overcome resistance in bladder cancer via dual suppression of CDK1/CDC5L and feedback-activated Akt/STAT3
作者
W. Jiang,Fei-Xue Yu,Yue-Xuan Liu,Y.H. Song,Chen-Kai Liu,Jue Liu,Liu Gao,Tian‐Rui Xu,Jun Sang